Sun Pharmaceutical Industries Ltd. — Board/Management Information 2021

May 20, 2021

May 20, 2021

National Stock Exchange of India Limited, Exchange Plaza, 5th Floor, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051 NSE Code – SUNPHARMA

BSE Limited, Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001. BSE Code – 524715

Dear Sirs / Madam,

• Sub: 1. Appointment of Dr. Pawan Goenka (DIN: 00254502) as an Additional Independent Director of the Company w.e.f. May 21, 2021.
  • 2. Appointment of Ms. Rama Bijapurkar (DIN: 00001835) as an Additional Independent Director of the Company w.e.f. May 21, 2021.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, by way of circular resolutions passed today i.e. on May 20, 2021, have:

• 1. approved the appointment of Dr. Pawan Goenka (DIN: 00254502), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021, to hold office upto the ensuing 29th Annual General Meeting of the Company.
• 1. approved the appointment of Ms. Rama Bijapurkar (DIN: 00001835), as an Additional Independent Director on the Board of the Company, with effect from May 21, 2021 to hold office upto the ensuing 29th Annual General Meeting of the Company.

We hereby confirm that Dr. Pawan Goenka and Ms. Rama Bijapurkar are not related to any Director of the Company and are also not related to each other. We also confirm that they both are not debarred from holding the office of Director by virtue of any order issued by the Securities and Exchange Board of India (SEBI) or any such other authority in accordance with the circular dated June 20, 2018, issued by the Stock Exchanges.

The disclosure(s) as required pursuant to Regulation 30 of the Listing Regulations read with Para A of Part A of Schedule III to the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 09, 2015 for Dr. Pawan Goenka and Ms. Rama Bijapurkar are given in Annexure 1 and Annexure 2 respectively, to this letter.

Thanking you,

Yours faithfully, For Sun Pharmaceutical Industries Limited Ashok Indulal Digitally signed by Ashok Indulal Bhuta

Ashok I. Bhuta Sr. GM - Secretarial & Compliance Officer Bhuta 22:42:58 +05'30'

Date: 2021.05.20

Encl: As above

Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.

Annexure 1

Disclosure pursuant to Regulation 30 of the Listing Regulations read with Para A of Part A of Schedule III to the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 09, 2015

1. Reason for change viz. appointment, resignation, removal, death or otherwise:

Appointment of Dr. Pawan Goenka (DIN: 00254502) as an Additional Independent Director of the Company

2. Date of appointment/cessation (as applicable) & term of appointment:

The appointment is effective from May 21, 2021.

As an Additional Independent Director, Dr. Pawan Goenka shall hold office upto the ensuing 29th Annual General Meeting of the Company or the last date on which the 29th Annual General Meeting should have been held, whichever is earlier.

3. Brief profile (in case of appointment):

Dr. Pawan Goenka earned his B. Tech. in Mechanical Engineering from IIT, Kanpur and Ph.D. from Cornell University, U.S.A. He is also a Graduate of Advanced Management Program from Harvard Business School. He worked at General Motors R&D Centre in Detroit, U.S.A. from 1979 to 1993. Thereafter, he joined Mahindra & Mahindra Ltd., as General Manager (R&D). During his R&D tenure he led the development of the Scorpio SUV. He was appointed COO (Automotive Sector) in April 2003, President (Automotive Sector) in September 2005, President (Automotive & Farm Equipment Sectors) in April 2010. Dr. Pawan Goenka was appointed Executive Director and President (AFS) on the Board of Mahindra & Mahindra Ltd. on 23rd September 2013. He retired from Mahindra as Managing Director and CEO on 1st April 2021. Dr. Goenka is credited with building a strong R&D and a wide product portfolio for Mahindra and is also widely recognised as a thought leader and statesman of the India Auto Industry.

Dr. Goenka served on the boards of several Mahindra Group Companies both domestic and International. He served as the Chairman of Mahindra Vehicle Manufacturers Limited, Mahindra Electric Mobility Limited, SsangYong Motor Company, Mahindra Racing UK Limited, Mahindra Automotive North America Inc., Mahindra USA, and Automobili Pininfarina GmbH. Dr. Goenka continues as the Non-Executive Chairman of Mahindra Agri Solutions Ltd (MASL).

Dr. Goenka has received several awards during his tenure in USA, such as the Extraordinary Accomplishment Award and the Charles L. McCuen Award from General Motors and the Burt L. Newkirk Award from ASME. He received the Distinguished Alumni Award from IIT Kanpur in 2004 and was also conferred with the Doctor of Science (honoris causa) in 2015. He is a

Fellow of SAE International and of The Indian National Academy of Engineers and a member of National Academy of Engineers, USA.

Dr. Pawan Goenka is a recipient of the Automotive Man of the Year award by NDTV Car & Bike, Autocar Professional's Man of the Year, and the CV Man of the Year by the Apollo CV Awards. Dr. Goenka has been awarded the 2016 FISITA Medal of Honour, which is bestowed for his 'particularly distinguished achievement and leadership in the global automotive industry' and is the first Indian to receive this prestigious recognition. He was presented with the Lifetime Achievement Award by Car India & Bike India in February 2020, the Param Shreshth Award by Car & Bike and the Lifetime Achievement Award by Autocar India, both in March 2021, for his leadership and contribution to the Indian Auto Industry.

Dr. Goenka is past President of SIAM, of the Society of Automotive Engineers India, the ARAI Governing Council, and also served as a Board Member of National Skills Development Corporation (NSDC). He is a National Council Member and the Chairman of the National Mission on AtmaNirbhar Bharat of Confederation of Indian Industries (CII). He is currently serving as the Chairman of the Board of Governors of IIT Madras and IIT Bombay. He is the Chairperson of the Steering Committee for Advancing Local value-add and Exports (SCALE), an initiative under the Ministry of Commerce & Industry, Department for Promotion of Industry and Internal Trade (Government of India).

4. Disclosure of relationships between directors (in case of appointment of a director):

Dr. Pawan Goenka is not related to any Director of the Company. He is also not related to Ms. Rama Bijapurkar who has also been appointed as Additional Independent Director with effect from May 21, 2021.

For Sun Pharmaceutical Industries Limited

Ashok Indulal Bhuta Digitally signed by Ashok Indulal Bhuta Date: 2021.05.20 22:43:23 +05'30'

Ashok I. Bhuta Sr. GM - Secretarial & Compliance Officer

Registered Office: SPARC, Tandalja, Vadodara – 390 012, Gujarat, INDIA.

Annexure 2

Disclosure pursuant to Regulation 30 of the Listing Regulations read with Para A of Part A of Schedule III to the Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/ 4/2015 dated September 09, 2015

1. Reason for change viz. appointment, resignation, removal, death or otherwise:

Appointment of Ms. Rama Bijapurkar (DIN: 00001835) as an Additional Independent Director of the Company

2. Date of appointment/cessation (as applicable) & term of appointment:

The appointment is effective from May 21, 2021.

As an Additional Independent Director, Ms. Rama Bijapurkar shall hold office upto the ensuing 29th Annual General Meeting of the Company or the last date on which the 29th Annual General Meeting should have been held, whichever is earlier.

3. Brief profile (in case of appointment):

Ms. Rama Bijapurkar is a recognised thought leader on business-market strategy and India's consumer economy. She has an independent management consulting practice, works across sectors, and describes her domain as bringing market focus to business strategy. She is a Professor of Management Practice at Indian Institute of Management, Ahmedabad, and cofounder of People Research on India's Consumer Economy, a not-for-profit think tank and fact tank, on India's economy and citizen environment for use in business strategy and public policy.

Ms. Bijapurkar is amongst India's most experienced independent board directors and has served on the boards of several of India's blue chip companies and public institutions.

Ms. Bijapurkar is a dominant voice in the Indian media on business and policy issues, and is the author of hallmark books on Consumer India "We are like that only: Understanding the Logic of Consumer India", "A Never-Before World: Tracking the Evolution of Consumer India" (Penguin) and "Customer in the Boardroom - crafting customer based business strategy" (Sage)

Ms. Bijapurkar holds a BSc (Hons) degree in Physics from Delhi University and a post graduate diploma in management from the Indian Institute of Management, Ahmedabad. Her over four decades of work experience in strategy consulting and market research includes her own consulting practice, and employment with McKinsey & Company, MARG (now Nielsen India), Mode Services (now TNS India).

4. Disclosure of relationships between directors (in case of appointment of a director):

Ms. Rama Bijapurkar is not related to any Director of the Company. She is also not related to Dr. Pawan Goenka who has also been appointed as Additional Independent Director with effect from May 21, 2021.

For Sun Pharmaceutical Industries Limited Ashok I. Bhuta Sr. GM - Secretarial & Compliance Officer Ashok Indulal Bhuta Digitally signed by Ashok Indulal Bhuta Date: 2021.05.20 22:43:42 +05'30'